ARTICLE | Company News
Genzyme, Valeant Pharmaceuticals sales and marketing update
February 14, 2011 8:00 AM UTC
Genzyme granted Valeant's Biovail Laboratories International SRL subsidiary rights to market Cholestagel colesevalem in Canada. The non-absorbed bile acid sequestrant is approved to treat hypercholes...